Skip to main content
    • Aa
    • Aa

Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort

  • K. T. D. EAMES (a1), E. BROOKS-POLLOCK (a1), D. PAOLOTTI (a2), M. PEROSA (a2), C. GIOANNINI (a2) and W. J. EDMUNDS (a1)...

The effectiveness of influenza vaccination programmes is seldom known during an epidemic. We developed an internet-based system to record influenza-like symptoms and response to infection in a participating cohort. Using self-reports of influenza-like symptoms and of influenza vaccine history and uptake, we estimated vaccine effectiveness (VE) without the need for individuals to seek healthcare. We found that vaccination with the 2010 seasonal influenza vaccine was significantly protective against influenza-like illness (ILI) during the 2010–2011 influenza season (VE 52%, 95% CI 27–68). VE for individuals who received both the 2010 seasonal and 2009 pandemic influenza vaccines was 59% (95% CI 27–77), slightly higher than VE for those vaccinated in 2010 alone (VE 46%, 95% CI 9–68). Vaccinated individuals with ILI reported taking less time off work than unvaccinated individuals with ILI (3·4 days vs. 5·3 days, P<0·001).

Corresponding author
*Author for correspondence: Dr K. T. D. Eames, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. (Email:
Hide All
1.Farrington CP. Estimation of vaccine effectiveness using the screening method. International Journal of Epidemiology 1993; 22: 742746.
2.Valenciano M, et al. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28: 73817388.
3.Kelly H, et al. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009; 4: e5079.
4.Skowronski DM, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25: 28422851.
5.Hardelid P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009–2010. Eurosurveillance 2011; 16: pii=19763.
6.Wichmann O, et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009–2010. Eurosurveillance 2010; 15: pii=19561.
7.Skowronski DM, et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. British Medical Journal 2011; 342: c7297.
8.Savulescu C, et al. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network – pilot case-control studies using different control groups, 2008–2009 season, Spain. Vaccine 2010; 28: 29032907.
9.Pebody R, et al. Effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Eurosurveillance 2011; 16: pii=19791.
10.Brooks-Pollock E, et al. Using an online survey of healthcare-seeking behaviour to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England. BMC Infectious Diseases 2011; 11: 68.
11.Tilston N, et al. Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health 2010; 10: 650.
12.Friesma I, et al. Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in the Netherlands. Vaccine 2009; 27: 63536357.
13.McNutt LA, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. American Journal of Epidemiology 2003; 157: 940943
14.Zou G. A modified Poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 2004; 159: 702706.
15.Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. Journal of the American Medical Association 1998; 280: 16901691.
16.Ihaka R, Gentleman R. R: A language for data analysis and graphics. Journal of Computational and Graphical Statistics 1996; 5: 299314.
17.StataCorp. Stata statistical software: release 11. College Station, TX: StataCorp LP, 2009.
18.HPA. HPA weekly national influenza report ( Accessed 8 March 2011.
19.Bridges CB, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults. Journal of the American Medical Association 2000; 284: 16551663.
20.Kissling E, et al. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Eurosurveillance 2011; 16: pii=19818.
21.Savulescu C, et al. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Eurosurveillance 2011; 16: pii=19820.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 4
Total number of PDF views: 13 *
Loading metrics...

Abstract views

Total abstract views: 169 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th October 2017. This data will be updated every 24 hours.